Internal Medicine, Hematology & Oncology · Broomall, PA
NPI
1508893926
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
30 Lawrence Rd, Suite 201
Broomall, PA, 19008
Phone (610) 492-5900
Groups this clinician bills Medicare through
Medicare paid, 2024
$723K
53,082 services
Medicare patients, 2024
320
Average age 74
Drug cost, 2024
$3.1M
846 prescriptions
Company payments, 2025
$1,894
From 35 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Peter D Ennis was code J1437 (injection, ferric derisomaltose, 10 mg), 1,700 times for 14 patients. In total Peter D Ennis billed 53,082 services in 93 codes, and Medicare paid $723K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-02-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 1,700 | 14 | $15.42 | $26K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 834 | 32 | $0.09 | $74.97 |
| 85025 Blood Count | Office | 721 | 227 | $7.39 | $5,327 |
| 36415 Venipuncture Blood Collection | Office | 609 | 209 | $8.52 | $5,190 |
| 99214 Office E&M - Established | Office | 332 | 150 | $97.70 | $32K |
| 99215 Office E&M - Established | Office | 212 | 89 | $135.81 | $29K |
| 99213 Office E&M - Established | Office | 167 | 95 | $68.17 | $11K |
| 99233 Hospital E&M - Subsequent | Facility | 114 | 62 | $95.38 | $11K |
| 96372 Injection Administration | Office | 102 | 29 | $11.57 | $1,180 |
| 96367 Intravenous Infusion, Hydration | Office | 78 | 30 | $23.31 | $1,818 |
| 85610 Clinical Chemistry | Office | 71 | 12 | $4.20 | $298 |
| J3490 Unclassified drugs | Office | 66 | 32 | $0.57 | $37.36 |
| 96365 Intravenous Infusion, Hydration | Office | 55 | 25 | $51.68 | $2,842 |
| 96413 Chemotherapy Administration | Office | 45 | 21 | $107.05 | $4,817 |
| 96361 Intravenous Infusion, Hydration | Office | 44 | 11 | $10.12 | $445 |
By year: 2022 $1.6M for 107,520 services; 2023 $1.1M for 78,185 services; 2024 $723K for 53,082 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 721 | 227 | $7.39 | $5,327 |
| 36415 Venipuncture Blood Collection | 609 | 209 | $8.52 | $5,190 |
| 85610 Clinical Chemistry | 71 | 12 | $4.20 | $298 |
Medicare prescription drug claims, 2024
In 2024, the drug Peter D Ennis prescribed most often to Medicare patients was Eliquis (Apixaban), with 102 prescriptions and refills. In total Peter D Ennis wrote 846 Medicare prescriptions that cost $3.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 102 | 179 | 24 | $100K |
| Hydroxyurea Generic | 58 | 135 | 13 | $1,876 |
| Xarelto Rivaroxaban | 48 | 103 | 11 | $55K |
| Dabigatran Etexilate Dabigatran Etexilate Mesylate | 46 | 70 | Under 11 | $11K |
| Famotidine Generic | 40 | 94 | 17 | $379 |
| Omeprazole Generic | 33 | 65 | 12 | $206 |
| Warfarin Sodium Generic | 32 | 86 | 11 | $584 |
| Procrit Epoetin Alfa | 30 | 30 | Under 11 | $31K |
| Pomalyst Pomalidomide | 29 | 29 | Under 11 | $644K |
| Promacta Eltrombopag Olamine | 26 | 26 | Under 11 | $448K |
| Prednisone Generic | 17 | 20 | Under 11 | $139 |
| Anastrozole Generic | 17 | 39 | Under 11 | $213 |
| Venclexta Venetoclax | 15 | 15 | Under 11 | $233K |
| Palonosetron Hcl Generic | 13 | 13 | Under 11 | $2,297 |
| Zolpidem Tartrate Generic | 13 | 13 | Under 11 | $35.33 |
Brand drugs: 388 claims; generic drugs: 458 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Peter D Ennis $1,894 ($1,894 in general payments such as food, travel and fees) from 35 companies. The largest payer was Shield Therapeutics Inc with $528.
| Company | Payments | Amount |
|---|---|---|
| Shield Therapeutics Inc STX.L | 23 | $528 |
| Abbvie Inc. ABBV | 9 | $182 |
| AstraZeneca Pharmaceuticals LP AZN | 7 | $153 |
| Janssen Biotech, Inc. JNJ | 4 | $98.75 |
| Eisai Inc. 4523.T | 3 | $85.53 |
| Pfizer Inc. PFE | 3 | $70.92 |
| Daiichi Sankyo Inc. 4568.T | 3 | $57.18 |
| BeOne Medicines USA, Inc. ONC | 2 | $52.47 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 2 | $46.84 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $39.88 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.